These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 6177606)

  • 1. Synthetic irreversible inhibitors of coagulation enzymes.
    Shaw E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):33-42. PubMed ID: 6177606
    [No Abstract]   [Full Text] [Related]  

  • 2. Approaches for designing synthetic, low molecular weight inhibitors of clotting enzymes.
    Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):7-15. PubMed ID: 6177611
    [No Abstract]   [Full Text] [Related]  

  • 3. From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3.
    Dönnecke D; Schweinitz A; Stürzebecher A; Steinmetzer P; Schuster M; Stürzebecher U; Nicklisch S; Stürzebecher J; Steinmetzer T
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3322-9. PubMed ID: 17462889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic inhibitors of serine proteinases. XXIII. Inhibition of factor Xa by diamidines.
    Stürzebecher J; Markwardt F; Walsmann P
    Thromb Res; 1980 Feb 1-15; 17(3-4):545-8. PubMed ID: 6989016
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of a new potent heparin. 2nd communication: Chemical analysis of the carbohydrate content and determination of the biological activity of a new potent heparin preparation in vitro, using protamine neutralization and amidolytic methods for factor Xa and thrombin.
    Bhargava AS; Heinick J; Günzel P
    Arzneimittelforschung; 1980; 30(7):1071-4. PubMed ID: 7191289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthesis of N-alpha-(arylsulfonylglycyl)-3-amidinophenylalanine esters as active and relatively specific inhibitors of factor Xa].
    Vieweg H; Wagner G
    Pharmazie; 1987 Apr; 42(4):268. PubMed ID: 3615560
    [No Abstract]   [Full Text] [Related]  

  • 7. Application of molecular connectivity and electro-topological indices in quantitative structure-activity analysis of pyrazole derivatives as inhibitors of factor Xa and thrombin.
    Krishnasamy C; Raghuraman A; Kier LB; Desai UR
    Chem Biodivers; 2008 Dec; 5(12):2609-20. PubMed ID: 19089820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Low molecular weight oligosaccharides active in plasma against factor Xa (author's transl)].
    Choay J; Lormeau JC; Petitou M
    Ann Pharm Fr; 1981 May; 39(1):37-44. PubMed ID: 7247232
    [No Abstract]   [Full Text] [Related]  

  • 9. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of pentosan polysulphate (SP54) and heparin. I: Mechanism of action on blood coagulation.
    Fischer AM; Barrowcliffe TW; Thomas DP
    Thromb Haemost; 1982 Apr; 47(2):104-8. PubMed ID: 6179182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tannins from Geum japonicum on the catalytic activity of thrombin and factor Xa of blood coagulation cascade.
    Dong H; Chen SX; Kini RM; Xu HX
    J Nat Prod; 1998 Nov; 61(11):1356-60. PubMed ID: 9834152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor X.
    Jackson CM
    Prog Hemost Thromb; 1984; 7():55-109. PubMed ID: 6397768
    [No Abstract]   [Full Text] [Related]  

  • 13. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Low molecular weight oligosaccharides active in plasma against factor Xa. II. New structural elements and antithrombotic activity (author's transl)].
    Choay J; Lormeau JC; Petitou M; Fareed J; Sinaÿ P
    Ann Pharm Fr; 1981 Jul; 39(3):267-72. PubMed ID: 7294654
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure/function analyses of recombinant variants of human factor Xa: factor Xa incorporation into prothrombinase on the thrombin-activated platelet surface is not mimicked by synthetic phospholipid vesicles.
    Larson PJ; Camire RM; Wong D; Fasano NC; Monroe DM; Tracy PB; High KA
    Biochemistry; 1998 Apr; 37(14):5029-38. PubMed ID: 9538022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor Xa or thrombin: is thrombin a better target?
    Weitz JI
    J Thromb Haemost; 2007 Jul; 5 Suppl 1():65-7. PubMed ID: 17635711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 18. [Anticoagulant effect of phosphatidylserine].
    Tersenov OA; Chabanov MK
    Vopr Med Khim; 1981; 27(5):619-23. PubMed ID: 7314577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Circulating anti-coagulant anti-prothrombinase and thrombosis: an association found in 5 out of 9 case reports].
    Goudemand J; Watel A; Ecroignard M; Marey A; Parquet A; Mazurier C; Dufay C; Cosson A
    LARC Med; 1982 May; 2(5):371-6. PubMed ID: 7167013
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic peptides and peptidomimetics as substrates and inhibitors of thrombin and other proteases in the blood coagulation system.
    Claeson G
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):411-36. PubMed ID: 8075312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.